Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Warnock

Showing results (211-220 of 371) with videos related to

Pageof 38
Sort By:
Journal of the American Society of Nephrology : JASN|September 13, 2015
Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal IschemiaJonatan Barrera-Chimal, Sonia Prince, Fouad Fadel, et al.
American Journal of Physiology. Renal Physiology|March 6, 2009
The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influxTao Na, Wei Zhang, Yi Jiang, et al.
Clinical Pharmacology and Therapeutics|March 1, 1989
Pharmacokinetics of esmolol and ASL-8123 in renal failureJ F Flaherty, B Wong, G La Follette, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Biologic regulation of Na/H antiporter activity in a cultured kidney cell line: effects of parathyroid hormone (PTH)A S Pollock, G J Strewler, R T Miller, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administrationVaughn W Folkert, Beckie Michael, Rajiv Agarwal, et al.
AJNR. American Journal of Neuroradiology|December 17, 2013
Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PETR Goetti, G Warnock, F P Kuhn, et al.
Molecular Genetics and Metabolism Reports|July 5, 2022
Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation studyChristoph Wanner, Virginia Kimonis, Juan Politei, et al.
The International Journal of Artificial Organs|June 7, 2007
Improving outcomes from acute kidney injury (AKI): Report on an initiativeC Ronco, A Levin, D G Warnock, et al.
Nephron|December 23, 2014
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuriaCamilla Tøndel, Takahiro Kanai, Kristin Kampevold Larsen, et al.
Diabetes|December 1, 1993
Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic isletsJ Kim, W Richter, H J Aanstoot, et al.
Pageof 38

Showing results (211-220 of 371) with videos related to

Sort By:
Pageof 38
Journal of the American Society of Nephrology : JASN|September 13, 2015
Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal IschemiaJonatan Barrera-Chimal, Sonia Prince, Fouad Fadel, et al.
American Journal of Physiology. Renal Physiology|March 6, 2009
The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influxTao Na, Wei Zhang, Yi Jiang, et al.
Clinical Pharmacology and Therapeutics|March 1, 1989
Pharmacokinetics of esmolol and ASL-8123 in renal failureJ F Flaherty, B Wong, G La Follette, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Biologic regulation of Na/H antiporter activity in a cultured kidney cell line: effects of parathyroid hormone (PTH)A S Pollock, G J Strewler, R T Miller, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administrationVaughn W Folkert, Beckie Michael, Rajiv Agarwal, et al.
AJNR. American Journal of Neuroradiology|December 17, 2013
Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PETR Goetti, G Warnock, F P Kuhn, et al.
Molecular Genetics and Metabolism Reports|July 5, 2022
Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation studyChristoph Wanner, Virginia Kimonis, Juan Politei, et al.
The International Journal of Artificial Organs|June 7, 2007
Improving outcomes from acute kidney injury (AKI): Report on an initiativeC Ronco, A Levin, D G Warnock, et al.
Nephron|December 23, 2014
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuriaCamilla Tøndel, Takahiro Kanai, Kristin Kampevold Larsen, et al.
Diabetes|December 1, 1993
Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic isletsJ Kim, W Richter, H J Aanstoot, et al.
Pageof 38